Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
335.6000 1.25 (0.37%)
NSE May 29, 2025 15:31 PM
Volume: 1.1M
 

logo
Biocon Ltd.
02 May 2017
335.60
0.37%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 1.5% YoY to | 931 crore (I-direct estimate: | 1055 crore) due to elongated approval timelines in emerging markets, discontinuance of in-licensed products and fire incident at Syngene EBITDA margins contracted 70 bps YoY to 20.1% (I-direct estimate: 25%) mainly due to higher raw material & employee cost. EBITDA declined 4.8% YoY to | 188 crore (I-direct estimate: | 264 crore) Net profit increased 106% YoY to | 127.5 crore (I-direct estimate:...
Number of FII/FPI investors increased from 297 to 305 in Mar 2025 qtr.
More from Biocon Ltd.
Recommended